Aperam confirmed Q3 outlook and Aperam stock gains 4.02 percent

Published on 10/09/2026 at 13:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q3 adjusted EBITDA is expected below EUR 130.00 million. Aperam stock costs EUR 39.06 on October 9, 2026 versus EUR 37.55, plus 4.02 percent.

Key points in brief

Aperam confirmed its third-quarter 2026 outlook on October 6, 2026, with adjusted EBITDA expected below EUR 130.00 million and above EUR 90.00 million.
The company-compiled consensus for third-quarter adjusted EBITDA is EUR 113.00 million.
Aperam stock was trading at EUR 39.06 at Lang & Schwarz on October 9, 2026, plus 4.02 percent versus the EUR 37.55 prior close.
Third-quarter and nine-month results are scheduled for November 6, 2026, followed by a capital markets day on November 18, 2026.

Aperam, LU0569974404, Illustration mit AI erstellt.

Aperam stock (ISIN LU0569974404) was trading at EUR 39.06 at Lang & Schwarz on October 9, 2026 at 1:43 p.m. CEST, up 4.02 percent versus the prior close of EUR 37.55. Aperam had confirmed its third-quarter outlook on October 6, 2026, with adjusted EBITDA expected below the second quarter's EUR 130.00 million but above the first quarter's EUR 90.00 million, according to Ideal Investor.

Aperam milestones carry three figures

On July 30, 2026, Aperam's first-half 2026 figures included EUR 3.264 billion of revenue, EUR 249.00 million of EBITDA and EUR 119.00 million of net income, as reported by Ideal Investor. On July 31, 2026, management reiterated a third-quarter adjusted EBITDA outcome between EUR 90.00 million and EUR 130.00 million. On October 6, 2026, the company restated that range and cited a company-compiled consensus of EUR 113.00 million, according to Ideal Investor.

What does the guidance mean for earnings?

The EUR 113.00 million consensus is EUR 17.00 million below the second-quarter reference of EUR 130.00 million, while it remains EUR 23.00 million above the first-quarter reference of EUR 90.00 million. That spread defines the near-term earnings test: seasonal demand and operating costs must allow Aperam to stay above the first-quarter base while limiting the decline from the second quarter.

The October update also described stronger seasonal activity in Brazil partly offsetting weaker European demand across Stainless, Recycling and Services & Solutions. Aperam's Leadership Journey Phase 6 targets EUR 150.00 million of gains from 2026 through 2028, with EUR 38.00 million already achieved in the first half of 2026, according to Ideal Investor.

Results and investor day dates

Aperam is scheduled to publish third-quarter and nine-month 2026 results before the market opens on November 6, 2026. A capital markets day is scheduled in Paris for November 18, 2026, according to Ideal Investor. The two dates give investors a defined sequence for testing the EUR 113.00 million consensus and the company's cost and demand assumptions.

Stock gains as earnings test approaches

At Lang & Schwarz, Aperam was trading at EUR 39.06 on October 9, 2026 at 1:43 p.m. CEST, plus 4.02 percent versus the EUR 37.55 prior close. The APAM.AS listing on Euronext Amsterdam was last at EUR 38.92 on October 9, 2026 at 1:31 p.m. CEST. The finance quote showed a market capitalization of EUR 2.8 billion and a 52-week range of EUR 29.50 to EUR 53.85 on October 9, 2026. The further course of trading is shown by the continuously updated real-time quote of Aperam stock.